M&A MVP: Skadden's Nancy Lieberman
Leading a multifaceted effort to help Amylin Pharmaceuticals Inc. extricate itself from litigation and complete a $7 billion sale to Bristol-Myers Squibb Co. highlighted a banner year for veteran Skadden Arps...To view the full article, register now.
Already a subscriber? Click here to view full article